Lb Pharmaceuticals LBRX
NASDAQ LBRX
$36.84 -0.44 (-1.18%)
As of: Oct 2, 2026 · 12:00 PM EDT

Lb Pharmaceuticals (LBRX) Change in Cash (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) posted Change in Cash of -$37.56 million for Q2 2026, compared with -$5.6 million a year earlier.

Analysis

Lb Pharmaceuticals (LBRX) Change in Cash (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Cash at Lb Pharmaceuticals was $269.16 million; for FY2025, it was $227.47 million.

  • In prior years, Lb Pharmaceuticals' Change in Cash was $8.5 million in FY2024.
  • According to Business Quant data, Change in Cash for the three prior quarters was $70.51 million (Q1 2026), -$19.31 million (Q4 2025) and $255.52 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -1.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -2.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.49 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 739.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.64 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.95 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -4.45 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -727.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 649.20 Mn
10 Lb Pharmaceuticals 1.10 Bn 1.10 Bn - -37.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -37.56 Mn
Mar 31, 2026 70.51 Mn
Dec 31, 2025 -19.31 Mn
Sep 30, 2025 255.52 Mn
Jun 30, 2025 -5.60 Mn
Mar 31, 2025 -3.15 Mn
Dec 31, 2024 7.87 Mn
API Access

Lb Pharmaceuticals Change in Cash API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-cash&ticker=LBRX&period=max&api_key=YOUR_API_KEY